124 related articles for article (PubMed ID: 10520223)
1. Effect of topical interleukin-1 receptor antagonist (IL-1ra) on corneal allograft survival in presensitized hosts.
Dekaris IJ; Yamada JJ; Streilein WJ; Dana RM
Curr Eye Res; 1999 Nov; 19(5):456-9. PubMed ID: 10520223
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 1 receptor antagonist suppresses allosensitization in corneal transplantation.
Yamada J; Dana MR; Zhu SN; Alard P; Streilein JW
Arch Ophthalmol; 1998 Oct; 116(10):1351-7. PubMed ID: 9790635
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
Yamada J; Zhu SN; Streilein JW; Dana MR
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
[TBL] [Abstract][Full Text] [Related]
4. Topical interleukin 1 receptor antagonist promotes corneal transplant survival.
Dana MR; Yamada J; Streilein JW
Transplantation; 1997 May; 63(10):1501-7. PubMed ID: 9175817
[TBL] [Abstract][Full Text] [Related]
5. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
[TBL] [Abstract][Full Text] [Related]
6. ICAM-1 deficiency suppresses host allosensitization and rejection of MHC-disparate corneal transplants.
Zhu SN; Yamada J; Streilein JW; Dana MR
Transplantation; 2000 Mar; 69(5):1008-13. PubMed ID: 10755569
[TBL] [Abstract][Full Text] [Related]
7. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens.
Sano Y; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1130-8. PubMed ID: 9152232
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice.
Sonoda Y; Sano Y; Ksander B; Streilein JW
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):427-34. PubMed ID: 7843911
[TBL] [Abstract][Full Text] [Related]
9. The effect of oral immunization on corneal allograft survival.
He YG; Mellon J; Niederkorn JY
Transplantation; 1996 Mar; 61(6):920-6. PubMed ID: 8623161
[TBL] [Abstract][Full Text] [Related]
10. Minor H, rather than MHC, alloantigens offer the greater barrier to successful orthotopic corneal transplantation in mice.
Sano Y; Ksander BR; Streilein JW
Transpl Immunol; 1996 Mar; 4(1):53-6. PubMed ID: 8762011
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 receptor antagonist eye drops promoting high-risk corneal allografts survival in rats.
Jie Y; Zhang WH; Pan ZQ; Wu YY; Wang Y
Chin Med J (Engl); 2004 May; 117(5):711-6. PubMed ID: 15161539
[TBL] [Abstract][Full Text] [Related]
12. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
Yamada J; Kurimoto I; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
[TBL] [Abstract][Full Text] [Related]
13. MHC-matched corneal allograft rejection in an IFN-gamma/IL-17-independent manner in C57BL/6 mice.
Yamada J; Hamuro J; Fukushima A; Ohteki T; Terai K; Iwakura Y; Yagita H; Kinoshita S
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2139-46. PubMed ID: 19136699
[TBL] [Abstract][Full Text] [Related]
14. Transplantation immunity and tolerance in the eye: rejection and acceptance of orthotopic corneal allografts in mice.
Holán V; Hasková Z; Filipec M
Transplantation; 1996 Oct; 62(8):1050-4. PubMed ID: 8900299
[TBL] [Abstract][Full Text] [Related]
15. T-cell mediated responses in a murine model of orthotopic corneal transplantation.
Joo CK; Pepose JS; Stuart PM
Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1530-40. PubMed ID: 7601633
[TBL] [Abstract][Full Text] [Related]
16. SEB combined with IL-1ra could prolong the survival of the rat allografts in high-risk corneal transplantation.
Jie Y; Pan Z; Chen Y; Wei Y; Zhang W; Xu L; Wu Y; Peng H
Transplant Proc; 2004 Dec; 36(10):3267-71. PubMed ID: 15686743
[TBL] [Abstract][Full Text] [Related]
17. Role of tumor necrosis factor receptors TNFR-I (P55) and TNFR-II (P75) in corneal transplantation.
Yamada J; Streilein JW; Dana MR
Transplantation; 1999 Oct; 68(7):944-9. PubMed ID: 10532532
[TBL] [Abstract][Full Text] [Related]
18. Topical soluble tumor necrosis factor receptor type I suppresses ocular chemokine gene expression and rejection of allogeneic corneal transplants.
Qian Y; Dekaris I; Yamagami S; Dana MR
Arch Ophthalmol; 2000 Dec; 118(12):1666-71. PubMed ID: 11115261
[TBL] [Abstract][Full Text] [Related]
19. Comparison of topical interleukin-1 vs tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis).
Dana R
Trans Am Ophthalmol Soc; 2007; 105():330-43. PubMed ID: 18427620
[TBL] [Abstract][Full Text] [Related]
20. Major histocompatibility complex semi-matching improves murine corneal allograft survival under oxidative macrophage dominancy.
Yamada J; Hamuro J; Terai K; Kinoshita S
Transplantation; 2007 Oct; 84(7):899-907. PubMed ID: 17984844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
